Control Bionics Limited (CBL.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 3.67 Million AUD | 4.8% |
| 2023 | 3.5 Million AUD | 45.87% |
| 2022 | 2.4 Million AUD | -3.86% |
| 2021 | 2.49 Million AUD | 1059.5% |
| 2020 | 215.51 Thousand AUD | 133.99% |
| 2019 | -634.06 Thousand AUD | -122.5% |
| 2018 | -284.97 Thousand AUD | -100.09% |
| 2017 | 323.69 Million NZD | 30.36% |
| 2016 | 248.31 Million NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 863.59 Thousand AUD | 0.0% |
| 2024 Q3 | 863.59 Thousand AUD | 205.0% |
| 2024 FY | -2.39 Million AUD | -168.36% |
| 2024 Q1 | 1.16 Million AUD | 266.49% |
| 2024 Q2 | -822.47 Thousand AUD | -170.7% |
| 2023 Q1 | 962.89 Thousand AUD | 156.16% |
| 2023 FY | 3.5 Million AUD | 45.87% |
| 2023 Q2 | -1.36 Million AUD | -241.5% |
| 2023 Q4 | -698.72 Thousand AUD | -167.27% |
| 2023 Q3 | 1.03 Million AUD | 176.23% |
| 2022 FY | 2.4 Million AUD | -3.86% |
| 2022 Q4 | -1.71 Million AUD | 0.0% |
| 2021 FY | 2.49 Million AUD | 1059.5% |
| 2020 FY | 215.51 Thousand AUD | 133.99% |
| 2019 FY | -634.06 Thousand AUD | -122.5% |
| 2018 FY | -284.97 Thousand AUD | -100.09% |
| 2017 FY | 323.69 Million NZD | 30.36% |
| 2016 FY | 248.31 Million NZD | 0.0% |
| 2016 Q4 | 80.92 Million NZD | 0.0% |
| 2016 Q3 | 80.92 Million NZD | 0.0% |
| 2016 Q2 | 80.92 Million NZD | 30.36% |
| 2016 Q1 | 62.07 Million NZD | 0.0% |
| 2015 Q2 | 62.07 Million NZD | 0.0% |
| 2015 Q4 | 62.07 Million NZD | 0.0% |
| 2015 Q3 | 62.07 Million NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -4.413% |
| Adherium Limited | -640.83 Thousand AUD | 673.124% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 93.197% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -155.639% |
| Anteris Technologies Ltd | 2.51 Million AUD | -45.908% |
| CardieX Limited | 10.1 Million AUD | 63.664% |
| Compumedics Limited | 26.06 Million AUD | 85.911% |
| Cochlear Limited | 1.69 Billion AUD | 99.783% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 67.667% |
| Cyclopharm Limited | 4.49 Million AUD | 18.334% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 67.263% |
| Nova Eye Medical Limited | 20.19 Million AUD | 81.812% |
| HeraMED Limited | -504.09 Thousand AUD | 828.588% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 284.294% |
| ImpediMed Limited | 9 Million AUD | 59.214% |
| InhaleRx Limited | 1.2 Million AUD | -205.036% |
| LBT Innovations Limited | -2.91 Million AUD | 225.909% |
| Micro-X Limited | 5.73 Million AUD | 35.981% |
| Neurotech International Limited | -5867.00 AUD | 62700.58% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -6501.913% |
| PolyNovo Limited | 36.08 Million AUD | 89.822% |
| Respiri Limited | 456.91 Thousand AUD | -703.822% |
| SomnoMed Limited | 55.13 Million AUD | 93.338% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 14.286% |
| Uscom Limited | 3.11 Million AUD | -17.88% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 1454.688% |